Determination and pharmacokinetics study of UK-5099 in mouse plasma by LC–MS/MS
Sign Up to like & getrecommendations! Published in 2022 at "BMC Veterinary Research"
DOI: 10.1186/s12917-022-03245-0
Abstract: Background UK-5099 is a potent mitochondrial acetone carrier inhibitor, that exhibits anticancer activity. Recently, the anti- Toxoplasma gondii activity of UK-5099 was proposed, and in vivo studies of its pharmacokinetics in BALB/c mice are necessary… read more here.
Keywords: determination pharmacokinetics; 5099 mouse; mouse plasma;